By combining new genetic models with transcriptomic, metabolomic, and electron microscopy approaches, we identified the Vnn1 pantetheinase as a tumor suppressor for the development of aggressive soft tissue sarcomas (STS). Here, VNN1 is linked to telomere syndrome.